Position in AMGN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$203,511
-$62,241 QoQ
Shares Held
562
-34.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#2,848
of 3,140 holders
Holding Since
Mar 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Core Wealth Partners LLC holds $9,914,904 across 8 Drug Manufacturers - General names. AMGN ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
11,580 | $2,940,972 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
18,313 | $2,313,664 | |
| 3 | ABBV |
AbbVie Inc.
|
6,948 | $1,748,394 | |
| 4 | LLY |
ELI LILLY & Co
|
1,132 | $1,357,754 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,447 | $828,439 | |
| 6 | PFE |
Pfizer Inc
|
11,587 | $279,014 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,220 | $243,156 | |
| 8 | AMGN |
Amgen Inc
This page
|
562 | $203,511 |
All Filings in AMGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $203,511 | 562 | Shares | Sole | 2026-07-17 | |
| 2025-03-31 | $265,752 | 853 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $356,816 | 1,369 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $483,637 | 1,501 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $328,697 | 1,052 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $299,388 | 1,053 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $280,819 | 975 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $255,322 | 950 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $210,919 | 950 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $205,487 | 850 | Shares | Sole | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||